Dare Bioscience (DARE) Gross Profit (2023 - 2026)
Dare Bioscience's (DARE) quarterly Gross Profit came in at $727877.0 in Q4 2025, up 1400.41% YoY from $48512.0 in Q4 2024, and up 32078.47% on a QoQ basis from $2262.0 in Q3 2025.
Dare Bioscience (DARE) Gross Profit (2023 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 3 years of Gross Profit data on file, last reported at $727877.0 in Q4 2025.
- Quarterly Gross Profit rose 1400.41% year-over-year to $727877.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $734394.0 (up 7406.07% YoY) and the FY2025 annual result came in at $734394.0, up 7406.07% from the prior year.
- Gross Profit improved to $727877.0 in Q4 2025, from $2262.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $1.0 million in Q3 2023 to a low of -$55973.0 in Q4 2024.
- A 3-year average of $193797.6 and a median of $22438.0 in 2024 frame the typical range for Gross Profit.
- The widest YoY moves for Gross Profit: up 1461.86% in 2025, down 194.36% in 2025.
- Tracing DARE's Gross Profit over 3 years: stood at $1.0 million in 2023, then slumped by 105.6% to -$55973.0 in 2024, then surged by 1400.41% to $727877.0 in 2025.
- The last three Gross Profit figures came in at $727877.0 (Q4 2025), $2262.0 (Q3 2025), and -$21172.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dare Bioscience | 12.36 Mn | -256,055.23 | -132,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -132,343.00 |
| Jun 30, 2026 | -132,343.00 |
| Dec 31, 2025 | 727,877.00 |
| Dec 31, 2025 | 727,877.00 |
| Sep 30, 2025 | 2,262.00 |
| Sep 30, 2025 | 2,262.00 |
| Jun 30, 2025 | -21,172.00 |
| Jun 30, 2025 | -21,172.00 |
| Mar 31, 2025 | 25,427.00 |
| Mar 31, 2025 | 25,427.00 |
| Dec 31, 2024 | -55,973.00 |
| Dec 31, 2024 | -55,973.00 |
| Sep 30, 2024 | 41,691.00 |
| Sep 30, 2024 | 41,691.00 |
| Jun 30, 2024 | 22,438.00 |
| Jun 30, 2024 | 22,438.00 |
| Mar 31, 2024 | 1,628.00 |
| Mar 31, 2024 | 1,628.00 |
| Sep 30, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.00 Mn |